nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergonovine—ABCB1—Methylprednisolone—multiple sclerosis	0.101	0.124	CbGbCtD
Ergonovine—CYP3A4—Fingolimod—multiple sclerosis	0.094	0.115	CbGbCtD
Ergonovine—ABCB1—Mitoxantrone—multiple sclerosis	0.0737	0.0901	CbGbCtD
Ergonovine—ABCB1—Betamethasone—multiple sclerosis	0.0657	0.0803	CbGbCtD
Ergonovine—ABCB1—Prednisolone—multiple sclerosis	0.0648	0.0793	CbGbCtD
Ergonovine—ABCB1—Prednisone—multiple sclerosis	0.0612	0.0749	CbGbCtD
Ergonovine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0606	0.074	CbGbCtD
Ergonovine—CYP3A4—Triamcinolone—multiple sclerosis	0.0459	0.0561	CbGbCtD
Ergonovine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0442	0.054	CbGbCtD
Ergonovine—CYP3A4—Betamethasone—multiple sclerosis	0.0394	0.0481	CbGbCtD
Ergonovine—CYP3A4—Prednisolone—multiple sclerosis	0.0388	0.0475	CbGbCtD
Ergonovine—ABCB1—Dexamethasone—multiple sclerosis	0.0382	0.0467	CbGbCtD
Ergonovine—CYP3A4—Prednisone—multiple sclerosis	0.0367	0.0449	CbGbCtD
Ergonovine—ABCB1—Methotrexate—multiple sclerosis	0.0307	0.0376	CbGbCtD
Ergonovine—CYP3A4—Dexamethasone—multiple sclerosis	0.0229	0.028	CbGbCtD
Ergonovine—Myasthenia gravis—Azathioprine—multiple sclerosis	0.00941	0.0731	CcSEcCtD
Ergonovine—Myasthenia gravis—Betamethasone—multiple sclerosis	0.00521	0.0405	CcSEcCtD
Ergonovine—Myasthenia gravis—Dexamethasone—multiple sclerosis	0.00521	0.0405	CcSEcCtD
Ergonovine—Bradycardia—Fingolimod—multiple sclerosis	0.00281	0.0218	CcSEcCtD
Ergonovine—Palpitations—Fingolimod—multiple sclerosis	0.00212	0.0165	CcSEcCtD
Ergonovine—Hypertension—Fingolimod—multiple sclerosis	0.00208	0.0161	CcSEcCtD
Ergonovine—Hypotension—Fingolimod—multiple sclerosis	0.00183	0.0142	CcSEcCtD
Ergonovine—Dyspnoea—Fingolimod—multiple sclerosis	0.00175	0.0136	CcSEcCtD
Ergonovine—Pulmonary oedema—Prednisolone—multiple sclerosis	0.0015	0.0116	CcSEcCtD
Ergonovine—Thrombophlebitis—Prednisolone—multiple sclerosis	0.00141	0.011	CcSEcCtD
Ergonovine—Pulmonary oedema—Triamcinolone—multiple sclerosis	0.00138	0.0107	CcSEcCtD
Ergonovine—Pulmonary oedema—Methylprednisolone—multiple sclerosis	0.00137	0.0107	CcSEcCtD
Ergonovine—Diarrhoea—Fingolimod—multiple sclerosis	0.00134	0.0104	CcSEcCtD
Ergonovine—Dizziness—Fingolimod—multiple sclerosis	0.0013	0.0101	CcSEcCtD
Ergonovine—Thrombophlebitis—Triamcinolone—multiple sclerosis	0.0013	0.0101	CcSEcCtD
Ergonovine—Thrombophlebitis—Methylprednisolone—multiple sclerosis	0.00129	0.01	CcSEcCtD
Ergonovine—Pulmonary oedema—Betamethasone—multiple sclerosis	0.00125	0.0097	CcSEcCtD
Ergonovine—Pulmonary oedema—Dexamethasone—multiple sclerosis	0.00125	0.0097	CcSEcCtD
Ergonovine—Headache—Fingolimod—multiple sclerosis	0.00123	0.00955	CcSEcCtD
Ergonovine—Thrombophlebitis—Betamethasone—multiple sclerosis	0.00118	0.00914	CcSEcCtD
Ergonovine—Thrombophlebitis—Dexamethasone—multiple sclerosis	0.00118	0.00914	CcSEcCtD
Ergonovine—Chest pain—Cladribine—multiple sclerosis	0.00116	0.00901	CcSEcCtD
Ergonovine—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.00113	0.00878	CcSEcCtD
Ergonovine—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.00112	0.00873	CcSEcCtD
Ergonovine—Sweating—Mitoxantrone—multiple sclerosis	0.0011	0.00854	CcSEcCtD
Ergonovine—Haematuria—Mitoxantrone—multiple sclerosis	0.00109	0.00849	CcSEcCtD
Ergonovine—Pulmonary oedema—Prednisone—multiple sclerosis	0.00109	0.00845	CcSEcCtD
Ergonovine—Hyperhidrosis—Cladribine—multiple sclerosis	0.00108	0.00835	CcSEcCtD
Ergonovine—Bradycardia—Mitoxantrone—multiple sclerosis	0.00105	0.00814	CcSEcCtD
Ergonovine—Hypotension—Cladribine—multiple sclerosis	0.00104	0.00807	CcSEcCtD
Ergonovine—Thrombophlebitis—Prednisone—multiple sclerosis	0.00102	0.00796	CcSEcCtD
Ergonovine—Dyspnoea—Cladribine—multiple sclerosis	0.000992	0.0077	CcSEcCtD
Ergonovine—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000927	0.0072	CcSEcCtD
Ergonovine—Myocardial infarction—Prednisolone—multiple sclerosis	0.000922	0.00716	CcSEcCtD
Ergonovine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00091	0.00707	CcSEcCtD
Ergonovine—Pulmonary oedema—Methotrexate—multiple sclerosis	0.000909	0.00706	CcSEcCtD
Ergonovine—HTR1E—brainstem—multiple sclerosis	0.00088	0.157	CbGeAlD
Ergonovine—Abdominal pain—Cladribine—multiple sclerosis	0.000879	0.00683	CcSEcCtD
Ergonovine—Bradycardia—Prednisolone—multiple sclerosis	0.00086	0.00668	CcSEcCtD
Ergonovine—Thrombophlebitis—Methotrexate—multiple sclerosis	0.000856	0.00665	CcSEcCtD
Ergonovine—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000853	0.00662	CcSEcCtD
Ergonovine—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000851	0.00661	CcSEcCtD
Ergonovine—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000848	0.00659	CcSEcCtD
Ergonovine—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000846	0.00657	CcSEcCtD
Ergonovine—Hypotension—Azathioprine—multiple sclerosis	0.000845	0.00657	CcSEcCtD
Ergonovine—Sweating—Methylprednisolone—multiple sclerosis	0.000827	0.00643	CcSEcCtD
Ergonovine—Bradycardia—Triamcinolone—multiple sclerosis	0.00079	0.00614	CcSEcCtD
Ergonovine—Bradycardia—Methylprednisolone—multiple sclerosis	0.000789	0.00613	CcSEcCtD
Ergonovine—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000774	0.00601	CcSEcCtD
Ergonovine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000774	0.00601	CcSEcCtD
Ergonovine—Hypertension—Mitoxantrone—multiple sclerosis	0.000773	0.00601	CcSEcCtD
Ergonovine—Hallucination—Methylprednisolone—multiple sclerosis	0.000771	0.00599	CcSEcCtD
Ergonovine—Myocardial infarction—Betamethasone—multiple sclerosis	0.000769	0.00598	CcSEcCtD
Ergonovine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000769	0.00598	CcSEcCtD
Ergonovine—Chest pain—Mitoxantrone—multiple sclerosis	0.000763	0.00592	CcSEcCtD
Ergonovine—Diarrhoea—Cladribine—multiple sclerosis	0.000761	0.00591	CcSEcCtD
Ergonovine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00074	0.00575	CcSEcCtD
Ergonovine—Dizziness—Cladribine—multiple sclerosis	0.000736	0.00571	CcSEcCtD
Ergonovine—Shock—Mitoxantrone—multiple sclerosis	0.000719	0.00559	CcSEcCtD
Ergonovine—Bradycardia—Betamethasone—multiple sclerosis	0.000717	0.00557	CcSEcCtD
Ergonovine—Bradycardia—Dexamethasone—multiple sclerosis	0.000717	0.00557	CcSEcCtD
Ergonovine—Abdominal pain—Azathioprine—multiple sclerosis	0.000715	0.00555	CcSEcCtD
Ergonovine—Vomiting—Cladribine—multiple sclerosis	0.000707	0.00549	CcSEcCtD
Ergonovine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000707	0.00549	CcSEcCtD
Ergonovine—Hallucination—Betamethasone—multiple sclerosis	0.000701	0.00545	CcSEcCtD
Ergonovine—Hallucination—Dexamethasone—multiple sclerosis	0.000701	0.00545	CcSEcCtD
Ergonovine—Headache—Cladribine—multiple sclerosis	0.000697	0.00541	CcSEcCtD
Ergonovine—Hypotension—Mitoxantrone—multiple sclerosis	0.000683	0.00531	CcSEcCtD
Ergonovine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000674	0.00523	CcSEcCtD
Ergonovine—Myocardial infarction—Prednisone—multiple sclerosis	0.00067	0.0052	CcSEcCtD
Ergonovine—Nausea—Cladribine—multiple sclerosis	0.000661	0.00513	CcSEcCtD
Ergonovine—Vertigo—Prednisolone—multiple sclerosis	0.00066	0.00513	CcSEcCtD
Ergonovine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000652	0.00506	CcSEcCtD
Ergonovine—Hypertension—Prednisolone—multiple sclerosis	0.000635	0.00493	CcSEcCtD
Ergonovine—Bradycardia—Prednisone—multiple sclerosis	0.000625	0.00485	CcSEcCtD
Ergonovine—Diarrhoea—Azathioprine—multiple sclerosis	0.000619	0.00481	CcSEcCtD
Ergonovine—Hallucination—Prednisone—multiple sclerosis	0.00061	0.00474	CcSEcCtD
Ergonovine—Vertigo—Triamcinolone—multiple sclerosis	0.000607	0.00472	CcSEcCtD
Ergonovine—Vertigo—Methylprednisolone—multiple sclerosis	0.000606	0.00471	CcSEcCtD
Ergonovine—Dizziness—Azathioprine—multiple sclerosis	0.000598	0.00465	CcSEcCtD
Ergonovine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000598	0.00464	CcSEcCtD
Ergonovine—Shock—Prednisolone—multiple sclerosis	0.00059	0.00458	CcSEcCtD
Ergonovine—Hypertension—Triamcinolone—multiple sclerosis	0.000584	0.00453	CcSEcCtD
Ergonovine—Hypertension—Methylprednisolone—multiple sclerosis	0.000582	0.00452	CcSEcCtD
Ergonovine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00058	0.0045	CcSEcCtD
Ergonovine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000578	0.00449	CcSEcCtD
Ergonovine—Vomiting—Azathioprine—multiple sclerosis	0.000575	0.00447	CcSEcCtD
Ergonovine—Headache—Azathioprine—multiple sclerosis	0.000567	0.0044	CcSEcCtD
Ergonovine—Vertigo—Betamethasone—multiple sclerosis	0.000551	0.00428	CcSEcCtD
Ergonovine—Vertigo—Dexamethasone—multiple sclerosis	0.000551	0.00428	CcSEcCtD
Ergonovine—Sweating—Methotrexate—multiple sclerosis	0.000548	0.00425	CcSEcCtD
Ergonovine—Haematuria—Methotrexate—multiple sclerosis	0.000545	0.00423	CcSEcCtD
Ergonovine—Shock—Triamcinolone—multiple sclerosis	0.000543	0.00422	CcSEcCtD
Ergonovine—Shock—Methylprednisolone—multiple sclerosis	0.000542	0.00421	CcSEcCtD
Ergonovine—Nausea—Azathioprine—multiple sclerosis	0.000537	0.00417	CcSEcCtD
Ergonovine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000533	0.00414	CcSEcCtD
Ergonovine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000532	0.00413	CcSEcCtD
Ergonovine—Hypertension—Dexamethasone—multiple sclerosis	0.000529	0.00411	CcSEcCtD
Ergonovine—Hypertension—Betamethasone—multiple sclerosis	0.000529	0.00411	CcSEcCtD
Ergonovine—Hypotension—Methylprednisolone—multiple sclerosis	0.000514	0.004	CcSEcCtD
Ergonovine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.0005	0.00389	CcSEcCtD
Ergonovine—Shock—Betamethasone—multiple sclerosis	0.000492	0.00383	CcSEcCtD
Ergonovine—Shock—Dexamethasone—multiple sclerosis	0.000492	0.00383	CcSEcCtD
Ergonovine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000492	0.00382	CcSEcCtD
Ergonovine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000484	0.00376	CcSEcCtD
Ergonovine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000484	0.00376	CcSEcCtD
Ergonovine—Vertigo—Prednisone—multiple sclerosis	0.00048	0.00373	CcSEcCtD
Ergonovine—Tinnitus—Methotrexate—multiple sclerosis	0.000478	0.00371	CcSEcCtD
Ergonovine—Hypotension—Betamethasone—multiple sclerosis	0.000468	0.00363	CcSEcCtD
Ergonovine—Hypotension—Dexamethasone—multiple sclerosis	0.000468	0.00363	CcSEcCtD
Ergonovine—Vomiting—Mitoxantrone—multiple sclerosis	0.000465	0.00361	CcSEcCtD
Ergonovine—HTR1E—nervous system—multiple sclerosis	0.000461	0.082	CbGeAlD
Ergonovine—Hypertension—Prednisone—multiple sclerosis	0.000461	0.00358	CcSEcCtD
Ergonovine—Headache—Mitoxantrone—multiple sclerosis	0.000458	0.00356	CcSEcCtD
Ergonovine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00045	0.0035	CcSEcCtD
Ergonovine—HTR1E—central nervous system—multiple sclerosis	0.000444	0.079	CbGeAlD
Ergonovine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000435	0.00338	CcSEcCtD
Ergonovine—Nausea—Mitoxantrone—multiple sclerosis	0.000434	0.00337	CcSEcCtD
Ergonovine—Shock—Prednisone—multiple sclerosis	0.000429	0.00333	CcSEcCtD
Ergonovine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000421	0.00327	CcSEcCtD
Ergonovine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000409	0.00318	CcSEcCtD
Ergonovine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000409	0.00318	CcSEcCtD
Ergonovine—Vertigo—Methotrexate—multiple sclerosis	0.000401	0.00312	CcSEcCtD
Ergonovine—HTR2C—brainstem—multiple sclerosis	0.000399	0.071	CbGeAlD
Ergonovine—Dizziness—Prednisolone—multiple sclerosis	0.000397	0.00308	CcSEcCtD
Ergonovine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000396	0.00307	CcSEcCtD
Ergonovine—Abdominal pain—Betamethasone—multiple sclerosis	0.000396	0.00307	CcSEcCtD
Ergonovine—Chest pain—Methotrexate—multiple sclerosis	0.00038	0.00295	CcSEcCtD
Ergonovine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000377	0.00293	CcSEcCtD
Ergonovine—Headache—Prednisolone—multiple sclerosis	0.000376	0.00292	CcSEcCtD
Ergonovine—Dizziness—Triamcinolone—multiple sclerosis	0.000365	0.00283	CcSEcCtD
Ergonovine—Dizziness—Methylprednisolone—multiple sclerosis	0.000364	0.00283	CcSEcCtD
Ergonovine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000356	0.00277	CcSEcCtD
Ergonovine—Nausea—Prednisolone—multiple sclerosis	0.000356	0.00277	CcSEcCtD
Ergonovine—HTR1E—brain—multiple sclerosis	0.000353	0.0627	CbGeAlD
Ergonovine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000352	0.00274	CcSEcCtD
Ergonovine—Vomiting—Triamcinolone—multiple sclerosis	0.000351	0.00272	CcSEcCtD
Ergonovine—Vomiting—Methylprednisolone—multiple sclerosis	0.00035	0.00272	CcSEcCtD
Ergonovine—Headache—Triamcinolone—multiple sclerosis	0.000346	0.00268	CcSEcCtD
Ergonovine—Headache—Methylprednisolone—multiple sclerosis	0.000345	0.00268	CcSEcCtD
Ergonovine—Abdominal pain—Prednisone—multiple sclerosis	0.000345	0.00268	CcSEcCtD
Ergonovine—Diarrhoea—Betamethasone—multiple sclerosis	0.000342	0.00266	CcSEcCtD
Ergonovine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000342	0.00266	CcSEcCtD
Ergonovine—Hypotension—Methotrexate—multiple sclerosis	0.00034	0.00264	CcSEcCtD
Ergonovine—Dizziness—Dexamethasone—multiple sclerosis	0.000331	0.00257	CcSEcCtD
Ergonovine—Dizziness—Betamethasone—multiple sclerosis	0.000331	0.00257	CcSEcCtD
Ergonovine—Nausea—Triamcinolone—multiple sclerosis	0.000328	0.00255	CcSEcCtD
Ergonovine—Nausea—Methylprednisolone—multiple sclerosis	0.000327	0.00254	CcSEcCtD
Ergonovine—Dyspnoea—Methotrexate—multiple sclerosis	0.000325	0.00252	CcSEcCtD
Ergonovine—Vomiting—Betamethasone—multiple sclerosis	0.000318	0.00247	CcSEcCtD
Ergonovine—Vomiting—Dexamethasone—multiple sclerosis	0.000318	0.00247	CcSEcCtD
Ergonovine—Headache—Dexamethasone—multiple sclerosis	0.000314	0.00244	CcSEcCtD
Ergonovine—Headache—Betamethasone—multiple sclerosis	0.000314	0.00244	CcSEcCtD
Ergonovine—ADRA1A—brainstem—multiple sclerosis	0.00031	0.0551	CbGeAlD
Ergonovine—Diarrhoea—Prednisone—multiple sclerosis	0.000298	0.00232	CcSEcCtD
Ergonovine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000298	0.00231	CcSEcCtD
Ergonovine—Nausea—Dexamethasone—multiple sclerosis	0.000297	0.00231	CcSEcCtD
Ergonovine—Nausea—Betamethasone—multiple sclerosis	0.000297	0.00231	CcSEcCtD
Ergonovine—Dizziness—Prednisone—multiple sclerosis	0.000288	0.00224	CcSEcCtD
Ergonovine—Abdominal pain—Methotrexate—multiple sclerosis	0.000288	0.00224	CcSEcCtD
Ergonovine—HTR2C—medulla oblongata—multiple sclerosis	0.000278	0.0495	CbGeAlD
Ergonovine—Vomiting—Prednisone—multiple sclerosis	0.000277	0.00215	CcSEcCtD
Ergonovine—Headache—Prednisone—multiple sclerosis	0.000273	0.00212	CcSEcCtD
Ergonovine—Nausea—Prednisone—multiple sclerosis	0.000259	0.00201	CcSEcCtD
Ergonovine—HTR2C—midbrain—multiple sclerosis	0.000254	0.0453	CbGeAlD
Ergonovine—Diarrhoea—Methotrexate—multiple sclerosis	0.000249	0.00194	CcSEcCtD
Ergonovine—HTR2C—spinal cord—multiple sclerosis	0.000248	0.0442	CbGeAlD
Ergonovine—Dizziness—Methotrexate—multiple sclerosis	0.000241	0.00187	CcSEcCtD
Ergonovine—Vomiting—Methotrexate—multiple sclerosis	0.000232	0.0018	CcSEcCtD
Ergonovine—Headache—Methotrexate—multiple sclerosis	0.000228	0.00177	CcSEcCtD
Ergonovine—Nausea—Methotrexate—multiple sclerosis	0.000216	0.00168	CcSEcCtD
Ergonovine—HTR2C—nervous system—multiple sclerosis	0.000209	0.0372	CbGeAlD
Ergonovine—HTR2C—central nervous system—multiple sclerosis	0.000201	0.0358	CbGeAlD
Ergonovine—ADRA1A—nervous system—multiple sclerosis	0.000162	0.0289	CbGeAlD
Ergonovine—HTR2C—brain—multiple sclerosis	0.00016	0.0284	CbGeAlD
Ergonovine—ADRA1A—central nervous system—multiple sclerosis	0.000156	0.0278	CbGeAlD
Ergonovine—ADRA1A—cerebellum—multiple sclerosis	0.000153	0.0272	CbGeAlD
Ergonovine—ABCB1—retina—multiple sclerosis	0.000127	0.0225	CbGeAlD
Ergonovine—ADRA1A—brain—multiple sclerosis	0.000124	0.0221	CbGeAlD
Ergonovine—CYP3A4—nervous system—multiple sclerosis	9.71e-05	0.0173	CbGeAlD
Ergonovine—HTR1E—GPCR ligand binding—POMC—multiple sclerosis	9.5e-05	0.00199	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CCR2—multiple sclerosis	9.49e-05	0.00199	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	9.4e-05	0.00197	CbGpPWpGaD
Ergonovine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	9.37e-05	0.00196	CbGpPWpGaD
Ergonovine—CYP3A4—central nervous system—multiple sclerosis	9.35e-05	0.0166	CbGeAlD
Ergonovine—HTR1E—GPCR ligand binding—CCL2—multiple sclerosis	9.29e-05	0.00195	CbGpPWpGaD
Ergonovine—ABCB1—medulla oblongata—multiple sclerosis	9.15e-05	0.0163	CbGeAlD
Ergonovine—HTR2C—GPCR downstream signaling—GPR65—multiple sclerosis	9.1e-05	0.00191	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CNR1—multiple sclerosis	8.93e-05	0.00187	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CCL3—multiple sclerosis	8.92e-05	0.00187	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	8.91e-05	0.00187	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCR1—multiple sclerosis	8.87e-05	0.00186	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CXCL13—multiple sclerosis	8.87e-05	0.00186	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CXCL10—multiple sclerosis	8.86e-05	0.00186	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	8.8e-05	0.00185	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CNR1—multiple sclerosis	8.76e-05	0.00184	CbGpPWpGaD
Ergonovine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	8.74e-05	0.00183	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—RGS1—multiple sclerosis	8.72e-05	0.00183	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—S1PR1—multiple sclerosis	8.72e-05	0.00183	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—PTGER4—multiple sclerosis	8.59e-05	0.0018	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	8.58e-05	0.0018	CbGpPWpGaD
Ergonovine—ABCB1—midbrain—multiple sclerosis	8.36e-05	0.0149	CbGeAlD
Ergonovine—HTR2C—GPCR downstream signaling—CXCL13—multiple sclerosis	8.32e-05	0.00174	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CCR1—multiple sclerosis	8.32e-05	0.00174	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CXCR3—multiple sclerosis	8.29e-05	0.00174	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—GPR65—multiple sclerosis	8.26e-05	0.00173	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—RGS1—multiple sclerosis	8.16e-05	0.00171	CbGpPWpGaD
Ergonovine—ABCB1—spinal cord—multiple sclerosis	8.16e-05	0.0145	CbGeAlD
Ergonovine—ADRA1A—GPCR ligand binding—CCR2—multiple sclerosis	8.07e-05	0.00169	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CXCL10—multiple sclerosis	8.04e-05	0.00169	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	8.03e-05	0.00168	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—LINGO1—multiple sclerosis	7.99e-05	0.00167	CbGpPWpGaD
Ergonovine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	7.97e-05	0.00167	CbGpPWpGaD
Ergonovine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.92e-05	0.00166	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CXCL10—multiple sclerosis	7.88e-05	0.00165	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—GPR65—multiple sclerosis	7.74e-05	0.00162	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	7.65e-05	0.0016	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	7.62e-05	0.0016	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—CCL5—multiple sclerosis	7.62e-05	0.0016	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	7.58e-05	0.00159	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCL13—multiple sclerosis	7.56e-05	0.00158	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCR1—multiple sclerosis	7.56e-05	0.00158	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	7.54e-05	0.00158	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	7.53e-05	0.00158	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CNR1—multiple sclerosis	7.45e-05	0.00156	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—RGS1—multiple sclerosis	7.41e-05	0.00155	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.32e-05	0.00154	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCL13—multiple sclerosis	7.08e-05	0.00148	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CCR1—multiple sclerosis	7.08e-05	0.00148	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—GPR65—multiple sclerosis	7.03e-05	0.00147	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TAGAP—multiple sclerosis	6.93e-05	0.00145	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CCL5—multiple sclerosis	6.92e-05	0.00145	CbGpPWpGaD
Ergonovine—ABCB1—nervous system—multiple sclerosis	6.88e-05	0.0122	CbGeAlD
Ergonovine—HTR1E—GPCR downstream signaling—CCR5—multiple sclerosis	6.87e-05	0.00144	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	6.83e-05	0.00143	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—LINGO1—multiple sclerosis	6.79e-05	0.00142	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CCL5—multiple sclerosis	6.79e-05	0.00142	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—IL2RA—multiple sclerosis	6.77e-05	0.00142	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CXCL10—multiple sclerosis	6.7e-05	0.00141	CbGpPWpGaD
Ergonovine—ABCB1—central nervous system—multiple sclerosis	6.62e-05	0.0118	CbGeAlD
Ergonovine—ABCB1—cerebellum—multiple sclerosis	6.47e-05	0.0115	CbGeAlD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6.46e-05	0.00135	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCL13—multiple sclerosis	6.43e-05	0.00135	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCR1—multiple sclerosis	6.43e-05	0.00135	CbGpPWpGaD
Ergonovine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.42e-05	0.00135	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	6.4e-05	0.00134	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCL3—multiple sclerosis	6.32e-05	0.00133	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	6.28e-05	0.00132	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CCR5—multiple sclerosis	6.24e-05	0.00131	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL2RA—multiple sclerosis	6.15e-05	0.00129	CbGpPWpGaD
Ergonovine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	6.14e-05	0.00129	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CCR5—multiple sclerosis	6.11e-05	0.00128	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PTGER4—multiple sclerosis	6.09e-05	0.00128	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—S1PR1—multiple sclerosis	6.06e-05	0.00127	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—PGR—multiple sclerosis	5.99e-05	0.00126	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—SRM—multiple sclerosis	5.97e-05	0.00125	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	5.95e-05	0.00125	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TAGAP—multiple sclerosis	5.89e-05	0.00123	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GPC5—multiple sclerosis	5.89e-05	0.00123	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CXCR3—multiple sclerosis	5.88e-05	0.00123	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CD28—multiple sclerosis	5.82e-05	0.00122	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.79e-05	0.00121	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CCL5—multiple sclerosis	5.77e-05	0.00121	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCR2—multiple sclerosis	5.72e-05	0.0012	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—PTGER4—multiple sclerosis	5.71e-05	0.0012	CbGpPWpGaD
Ergonovine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	5.55e-05	0.00116	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CXCR3—multiple sclerosis	5.51e-05	0.00116	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCL3—multiple sclerosis	5.38e-05	0.00113	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—POMC—multiple sclerosis	5.37e-05	0.00113	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CCR2—multiple sclerosis	5.36e-05	0.00112	CbGpPWpGaD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	5.34e-05	0.00112	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CNR1—multiple sclerosis	5.28e-05	0.00111	CbGpPWpGaD
Ergonovine—ABCB1—brain—multiple sclerosis	5.26e-05	0.00935	CbGeAlD
Ergonovine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.22e-05	0.00109	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CCR5—multiple sclerosis	5.2e-05	0.00109	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—PTGER4—multiple sclerosis	5.18e-05	0.00109	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—RGS1—multiple sclerosis	5.15e-05	0.00108	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—S1PR1—multiple sclerosis	5.15e-05	0.00108	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.12e-05	0.00107	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GPC5—multiple sclerosis	5.01e-05	0.00105	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCR3—multiple sclerosis	5.01e-05	0.00105	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CNR1—multiple sclerosis	4.95e-05	0.00104	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—GPR65—multiple sclerosis	4.88e-05	0.00102	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—POMC—multiple sclerosis	4.88e-05	0.00102	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCR2—multiple sclerosis	4.87e-05	0.00102	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—PTGER4—multiple sclerosis	4.85e-05	0.00102	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.79e-05	0.001	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—POMC—multiple sclerosis	4.78e-05	0.001	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—CCL2—multiple sclerosis	4.77e-05	0.001	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CXCL10—multiple sclerosis	4.75e-05	0.000996	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCR3—multiple sclerosis	4.69e-05	0.000983	CbGpPWpGaD
Ergonovine—HTR2C—GPCR ligand binding—CCL2—multiple sclerosis	4.68e-05	0.00098	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCL3—multiple sclerosis	4.58e-05	0.00096	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CCR2—multiple sclerosis	4.56e-05	0.000956	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CNR1—multiple sclerosis	4.49e-05	0.000942	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCR1—multiple sclerosis	4.46e-05	0.000936	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCL13—multiple sclerosis	4.46e-05	0.000936	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CXCL10—multiple sclerosis	4.46e-05	0.000934	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—PTGER4—multiple sclerosis	4.41e-05	0.000924	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—RGS1—multiple sclerosis	4.38e-05	0.000918	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—TYK2—multiple sclerosis	4.33e-05	0.000908	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCR3—multiple sclerosis	4.26e-05	0.000892	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CNR1—multiple sclerosis	4.21e-05	0.000882	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	4.21e-05	0.000882	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	4.21e-05	0.000882	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CD86—multiple sclerosis	4.15e-05	0.000871	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—GPR65—multiple sclerosis	4.15e-05	0.00087	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCR2—multiple sclerosis	4.14e-05	0.000868	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCL5—multiple sclerosis	4.09e-05	0.000857	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.08e-05	0.000854	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	4.06e-05	0.000852	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CXCL10—multiple sclerosis	4.05e-05	0.000848	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	3.98e-05	0.000833	CbGpPWpGaD
Ergonovine—HTR1E—GPCR downstream signaling—IL2—multiple sclerosis	3.97e-05	0.000832	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—GPC5—multiple sclerosis	3.85e-05	0.000807	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CCL5—multiple sclerosis	3.84e-05	0.000804	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	3.82e-05	0.000801	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	3.8e-05	0.000796	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	3.8e-05	0.000796	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	3.79e-05	0.000794	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—SPP1—multiple sclerosis	3.79e-05	0.000794	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCR5—multiple sclerosis	3.68e-05	0.000772	CbGpPWpGaD
Ergonovine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.68e-05	0.000772	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—SRM—multiple sclerosis	3.68e-05	0.000771	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL2RA—multiple sclerosis	3.63e-05	0.000761	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL2—multiple sclerosis	3.6e-05	0.000755	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCL5—multiple sclerosis	3.48e-05	0.00073	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—CCR5—multiple sclerosis	3.46e-05	0.000724	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	3.44e-05	0.000721	CbGpPWpGaD
Ergonovine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.41e-05	0.000715	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—IL2RA—multiple sclerosis	3.41e-05	0.000714	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—APOE—multiple sclerosis	3.35e-05	0.000703	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	3.26e-05	0.000684	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—RRM1—multiple sclerosis	3.19e-05	0.000668	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL3—multiple sclerosis	3.18e-05	0.000667	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCR5—multiple sclerosis	3.14e-05	0.000658	CbGpPWpGaD
Ergonovine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.13e-05	0.000656	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL2RA—multiple sclerosis	3.09e-05	0.000648	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PTGER4—multiple sclerosis	3.06e-05	0.000642	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CD80—multiple sclerosis	3.03e-05	0.000635	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—PGR—multiple sclerosis	3.02e-05	0.000632	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	2.96e-05	0.000621	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCR3—multiple sclerosis	2.96e-05	0.00062	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.94e-05	0.000617	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	2.94e-05	0.000616	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.93e-05	0.000615	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CD28—multiple sclerosis	2.93e-05	0.000614	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	2.9e-05	0.000607	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—POMC—multiple sclerosis	2.88e-05	0.000604	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.88e-05	0.000603	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCR2—multiple sclerosis	2.88e-05	0.000603	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—CCL2—multiple sclerosis	2.82e-05	0.000591	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—MAPK1—multiple sclerosis	2.76e-05	0.000578	CbGpPWpGaD
Ergonovine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.74e-05	0.000574	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	2.7e-05	0.000567	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—POMC—multiple sclerosis	2.7e-05	0.000566	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	2.67e-05	0.000559	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CNR1—multiple sclerosis	2.65e-05	0.000556	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	2.63e-05	0.000551	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	2.6e-05	0.000546	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.59e-05	0.000543	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.59e-05	0.000543	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	2.56e-05	0.000537	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TYK2—multiple sclerosis	2.56e-05	0.000536	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	2.51e-05	0.000527	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	2.49e-05	0.000522	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—POMC—multiple sclerosis	2.45e-05	0.000514	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	2.45e-05	0.000513	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—CCL2—multiple sclerosis	2.4e-05	0.000503	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CXCL10—multiple sclerosis	2.39e-05	0.000501	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.37e-05	0.000497	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	2.3e-05	0.000481	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	2.26e-05	0.000473	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	2.18e-05	0.000457	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL2—multiple sclerosis	2.13e-05	0.000446	CbGpPWpGaD
Ergonovine—HTR1E—Signaling by GPCR—IL6—multiple sclerosis	2.12e-05	0.000444	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CD86—multiple sclerosis	2.09e-05	0.000438	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	2.09e-05	0.000437	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	2.06e-05	0.000431	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	2.04e-05	0.000428	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	2.03e-05	0.000426	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MMP9—multiple sclerosis	2.01e-05	0.000422	CbGpPWpGaD
Ergonovine—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	2e-05	0.000419	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.96e-05	0.000412	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	1.91e-05	0.000399	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	1.85e-05	0.000389	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	1.85e-05	0.000388	CbGpPWpGaD
Ergonovine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.84e-05	0.000386	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.83e-05	0.000384	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	1.83e-05	0.000383	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	1.81e-05	0.00038	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—STAT3—multiple sclerosis	1.79e-05	0.000376	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	1.78e-05	0.000373	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	1.75e-05	0.000367	CbGpPWpGaD
Ergonovine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	1.7e-05	0.000356	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—APOE—multiple sclerosis	1.69e-05	0.000354	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MYC—multiple sclerosis	1.66e-05	0.000349	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—TGFB1—multiple sclerosis	1.66e-05	0.000348	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—MAPK1—multiple sclerosis	1.63e-05	0.000341	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.62e-05	0.00034	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.58e-05	0.00033	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.55e-05	0.000326	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.54e-05	0.000323	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.52e-05	0.00032	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.45e-05	0.000304	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.43e-05	0.000301	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.42e-05	0.000297	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.39e-05	0.000291	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.3e-05	0.000272	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.29e-05	0.00027	CbGpPWpGaD
Ergonovine—HTR1E—Signaling Pathways—IL6—multiple sclerosis	1.25e-05	0.000262	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	1.23e-05	0.000258	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	1.21e-05	0.000253	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.18e-05	0.000247	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.000237	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—APOE—multiple sclerosis	1.1e-05	0.000231	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	1.09e-05	0.000229	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	1.07e-05	0.000225	CbGpPWpGaD
Ergonovine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	1.07e-05	0.000223	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	1.01e-05	0.000212	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—POMC—multiple sclerosis	9.46e-06	0.000198	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	9.11e-06	0.000191	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	9.06e-06	0.00019	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	9.01e-06	0.000189	CbGpPWpGaD
Ergonovine—ABCB1—Metabolism—ALB—multiple sclerosis	8.63e-06	0.000181	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	8.62e-06	0.000181	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	8.37e-06	0.000176	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	8.35e-06	0.000175	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	8.19e-06	0.000172	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	7.66e-06	0.000161	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	7.12e-06	0.000149	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	7.1e-06	0.000149	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	6.97e-06	0.000146	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—APOE—multiple sclerosis	6.79e-06	0.000142	CbGpPWpGaD
Ergonovine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	6.3e-06	0.000132	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—POMC—multiple sclerosis	5.83e-06	0.000122	CbGpPWpGaD
Ergonovine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	5.35e-06	0.000112	CbGpPWpGaD
Ergonovine—CYP3A4—Metabolism—ALB—multiple sclerosis	5.32e-06	0.000111	CbGpPWpGaD
